OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging roles of N6-methyladenosine (m6A) modification in breast cancer
Yanyan Wang, Yujie Zhang, Yushen Du, et al.
Cell & Bioscience (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
Hengyu Chen, Yuanhang Yu, Ming Yang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 76

Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 58

Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
Desh Deepak Singh, Amna Parveen, Dharmendra Kumar Yadav
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1512-1512
Open Access | Times Cited: 51

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
Liting Guo, Yang Hui, Chenfei Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31

The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer
Wenzhang Wu, Fan Zhang, Jun Zhao, et al.
Experimental Cell Research (2022) Vol. 415, Iss. 2, pp. 113115-113115
Closed Access | Times Cited: 19

Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors
Jiongyu Chen, Yixuan Zhuang, Ping Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 18

Integrated analysis on the N6‐methyladenosine‐related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma
Yuqin Qiu, Xiaogang Wang, Zhenjia Fan, et al.
Immunity Inflammation and Disease (2021) Vol. 9, Iss. 4, pp. 1596-1612
Open Access | Times Cited: 23

The role of m6A methylation in osteosarcoma biological processes and its potential clinical value
Yanjiao Wu, Zhiyun Wang, Jianlin Shen, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 17

m6A RNA Methylation in Systemic Autoimmune Diseases—A New Target for Epigenetic-Based Therapy?
Anna Wardowska
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 218-218
Open Access | Times Cited: 22

Crosstalk among N6-methyladenosine modification and RNAs in central nervous system injuries
Mi Tian, Lei Mao, Li Zhang
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 15

Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation
Hannah Petraitis Kuschman, Marianne B. Palczewski, Brian M. Hoffman, et al.
Redox Biology (2023) Vol. 67, pp. 102928-102928
Open Access | Times Cited: 6

Determination of adenosine and its modifications in urine and plasma from breast cancer patients by hydrophilic interaction liquid chromatography-tandem mass spectrometry
Xiaoxiao Zhang, Yiqiu Hu, Xiujuan Hong, et al.
Journal of Chromatography B (2022) Vol. 1209, pp. 123428-123428
Closed Access | Times Cited: 10

T helper cell-mediated epitranscriptomic regulation via m6A RNA methylation bridges link between coronary artery disease and invasive ductal carcinoma
Sudeshna Rakshit, Jithin S. Sunny, Melvin George, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 12, pp. 3421-3436
Closed Access | Times Cited: 9

Functions and mechanisms of RNA m6A regulators in breast cancer (Review)
Yibei Yang, Feng Gao, Lanqi Ren, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Open Access | Times Cited: 1

Specific recognition between YTHDF3 and m6A‐modified RNA: An all‐atom molecular dynamics simulation study
Wenxue Zhou, Zhongjie Han, Zhixiang Wu, et al.
Proteins Structure Function and Bioinformatics (2022) Vol. 90, Iss. 11, pp. 1965-1972
Closed Access | Times Cited: 5

N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy
Mengmeng Zhang, Yilin Lin, Wenfeng Zeng, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 6

FTO genotype was associated with breast cancer in HER2 negative patients
Fateme Montazeri, Hossein Hatami, Soroor Fathi, et al.
Clinical Nutrition ESPEN (2022) Vol. 49, pp. 495-498
Closed Access | Times Cited: 4

Roles of RNA m6A modification in nonalcoholic fatty liver disease
Jian Tan, Yue-fan Wang, Zhihui Dai, et al.
Hepatology Communications (2023) Vol. 7, Iss. 2, pp. e0046-e0046
Open Access | Times Cited: 1

Advances in research of m6A methylation in hepatocellular carcinoma
Song Jin, Xiaonian Zhu, Sheng-Kui Tan
Shijie huaren xiaohua zazhi (2021) Vol. 29, Iss. 13, pp. 720-725
Open Access

Page 1

Scroll to top